HK1002610A1 - Method and composition for determining the immunological activity of bioactive substances - Google Patents

Method and composition for determining the immunological activity of bioactive substances

Info

Publication number
HK1002610A1
HK1002610A1 HK98101626A HK98101626A HK1002610A1 HK 1002610 A1 HK1002610 A1 HK 1002610A1 HK 98101626 A HK98101626 A HK 98101626A HK 98101626 A HK98101626 A HK 98101626A HK 1002610 A1 HK1002610 A1 HK 1002610A1
Authority
HK
Hong Kong
Prior art keywords
bioactive substances
immunological activity
tested
solution
determining
Prior art date
Application number
HK98101626A
Other languages
English (en)
Inventor
Anna Inglot
Zofia Blach-Olszewska
Original Assignee
Torf Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Ets filed Critical Torf Ets
Publication of HK1002610A1 publication Critical patent/HK1002610A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK98101626A 1991-10-26 1998-03-03 Method and composition for determining the immunological activity of bioactive substances HK1002610A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (de) 1991-10-26 1991-10-26 Verfahren und Zusammensetzung zur Bestimmung der Immunologischen Aktivität von aktiven Substanzen enthaltende Lösungen
PCT/EP1992/002228 WO1993008470A1 (en) 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances

Publications (1)

Publication Number Publication Date
HK1002610A1 true HK1002610A1 (en) 1998-09-04

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98101626A HK1002610A1 (en) 1991-10-26 1998-03-03 Method and composition for determining the immunological activity of bioactive substances

Country Status (23)

Country Link
US (1) US5543300A (de)
EP (2) EP0539610A1 (de)
JP (1) JPH07500905A (de)
AT (1) ATE153763T1 (de)
AU (1) AU678343B2 (de)
BG (1) BG61705B1 (de)
CA (1) CA2122131A1 (de)
CZ (1) CZ100494A3 (de)
DE (3) DE539610T1 (de)
DK (1) DK0609255T3 (de)
ES (1) ES2061424T3 (de)
FI (1) FI941920A0 (de)
GR (3) GR930300100T1 (de)
HK (1) HK1002610A1 (de)
HU (1) HU216863B (de)
LV (1) LV12140B (de)
NO (1) NO941444L (de)
PL (1) PL170592B1 (de)
RO (1) RO114837B1 (de)
RU (1) RU2125727C1 (de)
SG (1) SG72665A1 (de)
SK (1) SK44094A3 (de)
WO (1) WO1993008470A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
EP1115408B1 (de) * 1998-09-23 2006-01-25 Pfeinsmith Limited Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
DE60304989T2 (de) * 2003-02-18 2007-03-29 Clinique La Prairie Research S.A. Zusammensetzungen enthaltend fötales Hämoglobin und bakterielles Endotoxin und fakultativ zusätzliche fötale Leberkomponenten
US7497947B2 (en) * 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
US9005449B2 (en) 2011-09-07 2015-04-14 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
DE3782958D1 (de) * 1986-02-19 1993-01-21 Imreg Inc Verfahren und mittel zum pruefen eines immunsystems.
DE3779909T2 (de) * 1986-03-06 1993-01-07 Commw Scient Ind Res Org In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
ATE131859T1 (de) * 1991-03-16 1996-01-15 Torf Ets Verfahren zur kontinuierlichen extraction von torf und apparat zur durchführung dieses verfahrens

Also Published As

Publication number Publication date
EP0539610A1 (de) 1993-05-05
GR930300100T1 (de) 1993-10-29
NO941444D0 (no) 1994-04-21
DK0609255T3 (da) 1997-12-22
BG61705B1 (bg) 1998-03-31
HU9401185D0 (en) 1994-07-28
AU2650992A (en) 1993-05-21
WO1993008470A1 (en) 1993-04-29
US5543300A (en) 1996-08-06
CZ100494A3 (en) 1994-11-16
DE609255T1 (de) 1995-06-14
JPH07500905A (ja) 1995-01-26
EP0609255B1 (de) 1997-05-28
DE69220078D1 (de) 1997-07-03
GR940300077T1 (en) 1994-11-30
EP0609255A1 (de) 1994-08-10
SK44094A3 (en) 1995-03-08
LV12140A (lv) 1998-09-20
ATE153763T1 (de) 1997-06-15
HU216863B (hu) 1999-09-28
ES2061424T3 (es) 1997-10-01
DE69220078T2 (de) 1997-12-04
BG98720A (bg) 1995-07-28
RU2125727C1 (ru) 1999-01-27
RU94022481A (ru) 1996-09-27
CA2122131A1 (en) 1993-04-29
LV12140B (lv) 1998-12-20
AU678343B2 (en) 1997-05-29
NO941444L (no) 1994-06-16
FI941920A (fi) 1994-04-25
DE539610T1 (de) 1993-12-16
PL170592B1 (en) 1997-01-31
HUT69990A (en) 1995-09-28
SG72665A1 (en) 2000-05-23
GR3024457T3 (en) 1997-11-28
ES2061424T1 (es) 1994-12-16
FI941920A0 (fi) 1994-04-25
RO114837B1 (ro) 1999-07-30

Similar Documents

Publication Publication Date Title
DE69003652D1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
AU9058091A (en) Preparation of nucleic acid samples
HU9401185D0 (en) Method and composition for determining the immunological activity of bioactive substances
EP0376251A3 (en) An anticoagulant substance obtained from urine
DK1092437T3 (da) Anvendelse af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel
NO893135L (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
Müller Influence of ionizing radiation on the appearance in the serum of rabbits of humoral factors slowing down cell division
ATE4216T1 (de) 3-hydrocarbylthio-2-acyloxypropyl 2trimethylammonioethyl phosphate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
DK183788D0 (da) Fremgangsmaade til foroegelse af levedygtigheden af frysetoerrede, maelkesyreproducerende bakteriekulturkoncentrater
ATE135702T1 (de) Aryl- oder heteroaryl-1-alkyl-pyrrol-2- carbonsäure-derivate, zur behandlung von durch interleukin-1 hervorgerufenen erkrankungen
DE3861273D1 (de) Taurinderivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen.
DE69019431D1 (de) Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions.
FR2645865B1 (fr) Procede de preparation de la proteine c activee et solution de proteine c activee ainsi obtenue
ATE53384T1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.
JPS5722688A (en) Concentration of liquid containing nutrient component
ATE13633T1 (de) Verfahren zur herstellung von hochgereinigtem antihaemophiliefaktor.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)